Author details

Full Name

Chantal Pauli

Affiliation

University Hospital Zurich

ORCID

Career Start Year

2001

Papers

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
36316541	Establishment, characterization and functional testing of two novel ex vivo extraskeletal myxoid chondrosarcoma (EMC) cell models.	Hum Cell	2023
37079060	[CUP syndrome-diagnostics from the perspective of pathology].	Radiologie (Heidelb)	2023
37225644	NKX3.1 immunohistochemistry and methylome profiling in mesenchymal chondrosarcoma: additional diagnostic value for a well-defined disease?	Pathology	2023
36779660	Unravelling homologous recombination repair deficiency and therapeutic opportunities in soft tissue and bone sarcoma.	EMBO Mol Med	2023
36870294	Addressing Modern Diagnostic Pathology for Patient-Derived Soft Tissue Sarcosphere Models in the Era of Functional Precision Oncology.	Lab Invest	2023
36759438	A systematic comparison of pan-Trk immunohistochemistry assays among multiple cancer types.	Histopathology	2023
34728552	A Functional Precision Oncology Approach to Identify Treatment Strategies for Myxofibrosarcoma Patients.	Mol Cancer Res	2022
35510953	Inhibition of FGF receptor blocks adaptive resistance to RET inhibition in CCDC6-RET-rearranged thyroid cancer.	J Exp Med	2022
35820737	Prediction of histology by B-mode and PD-mode ultrasound across different joint locations and diseases.	RMD Open	2022
36001976	SF3B1 facilitates HIF1-signaling and promotes malignancy in pancreatic cancer.	Cell Rep	2022
35864317	Molecular and immunophenotypic characterization of SMARCB1 (INI1) - deficient intrathoracic Neoplasms.	Mod Pathol	2022
36007219	MTPpilot: An Interactive Software for Visualization of Next-Generation Sequencing Results in Molecular Tumor Boards.	JCO Clin Cancer Inform	2022
33486519	Targeted therapies and checkpoint inhibitors in sarcoma.	QJM	2022
35187519	Drug screening and genome editing in human pancreatic cancer organoids identifies drug-gene interactions and candidates for off-label treatment.	Cell Genom	2022
31266731	Tracing Clonal Dynamics Reveals that Two- and Three-dimensional Patient-derived Cell Models Capture Tumor Heterogeneity of Clear Cell Renal Cell Carcinoma.	Eur Urol Focus	2021
33484560	Site of Recurrence and Survival After Surgery for Colorectal Peritoneal Metastasis.	J Natl Cancer Inst	2021
33687747	A Challenging Task: Identifying Patients with Cancer of Unknown Primary (CUP) According to ESMO Guidelines: The CUPISCO Trial Experience.	Oncologist	2021
33984270	PI5P4Ks drive metabolic homeostasis through peroxisome-mitochondria interplay.	Dev Cell	2021
33372007	Metastasis and Immune Evasion from Extracellular cGAMP Hydrolysis.	Cancer Discov	2021
32290812	Challenges in diagnosis and management of neutropenia upon exposure to immune-checkpoint inhibitors: meta-analysis of a rare immune-related adverse side effect.	BMC Cancer	2020
30898933	High-fructose corn syrup enhances intestinal tumor growth in mice.	Science	2019
31696117	Cancer Sample Biobanking at the Next Level: Combining Tissue With Living Cell Repositories to Promote Precision Medicine.	Front Cell Dev Biol	2019
31592503	Integrative Molecular Analysis of Patients With Advanced and Metastatic Cancer.	JCO Precis Oncol	2019
29266381	Bone biopsy protocol for advanced prostate cancer in the era of precision medicine.	Cancer	2018
30158705	Publisher Correction: Suppression of insulin feedback enhances the efficacy of PI3K inhibitors.	Nature	2018
30051890	Suppression of insulin feedback enhances the efficacy of PI3K inhibitors.	Nature	2018
29921838	Patient derived organoids to model rare prostate cancer phenotypes.	Nat Commun	2018
29727621	Phosphatidylinositol-5-Phosphate 4-Kinases Regulate Cellular Lipid Metabolism By Facilitating Autophagy.	Mol Cell	2018
29411909	Gene expression profiles of the meniscus avascular phenotype: A guide for meniscus tissue engineering.	J Orthop Res	2018
29374691	Exploratory Radiomics in Computed Tomography Perfusion of Prostate Cancer.	Anticancer Res	2018
29311302	Fenofibrate prevents skeletal muscle loss in mice with lung cancer.	Proc Natl Acad Sci U S A	2018
29342134	Chromosomal instability drives metastasis through a cytosolic DNA response.	Nature	2018
27925477	Relevance of meniscal cell regional phenotype to tissue engineering.	Connect Tissue Res	2017
28459450	Transplantation of engineered organoids enables rapid generation of metastatic mouse models of colorectal cancer.	Nat Biotechnol	2017
28161394	Magic angle effect plays a major role in both T1rho and T2 relaxation in articular cartilage.	Osteoarthritis Cartilage	2017
28331002	Personalized In Vitro and In Vivo Cancer Models to Guide Precision Medicine.	Cancer Discov	2017
28373416	On-site Cytology for Development of Patient-Derived Three-dimensional Organoid Cultures - A Pilot Study.	Anticancer Res	2017
29333526	Next-Generation Rapid Autopsies Enable Tumor Evolution Tracking and Generation of Preclinical Models.	JCO Precis Oncol	2017
28956107	[Establishment of aÂ living biobank : Improved guidance of precision cancer care with in vitro and in vivo cancer models].	Pathologe	2017
28717538	Assessment of prostate cancer with integrated CT-perfusion using a sector-wise approach.	Turk J Urol	2017
26641771	An emerging role for cytopathology in precision oncology.	Cancer Cytopathol	2016
26382110	UTE bi-component analysis of T2* relaxation in articular cartilage.	Osteoarthritis Cartilage	2016
25808266	Off-resonance saturation ratio obtained with ultrashort echo time-magnetization transfer techniques is sensitive to changes in static tensile loading of tendons and degeneration.	J Magn Reson Imaging	2015
26261782	Quantitative bi-component T2* analysis of histologically normal Achilles tendons.	Muscles Ligaments Tendons J	2015
26181256	Whole-Exome Sequencing of Metastatic Cancer and Biomarkers of Treatment Response.	JAMA Oncol	2015
25877206	MAGI3-AKT3 fusion in breast cancer amended.	Nature	2015
25956431	Prognostic value of tumor suppressors in osteosarcoma before and after neoadjuvant chemotherapy.	BMC Cancer	2015
24450990	Multiparametric PET/CT-perfusion does not add significant additional information for initial staging in lung cancer compared with standard PET/CT.	EJNMMI Res	2014
25168905	Integrated CT-perfusion shows no meaningful correlation with PSA and presurgical Gleason score in patients with early prostate cancer.	Clin Imaging	2014
24710202	Assessment of prostate cancer with dynamic contrast-enhanced computed tomography using an en bloc approach.	Invest Radiol	2014

1 - 50 of 64

Daniel J McGrail

Center for Immunotherapy and Precision Immuno-Oncology, Cleveland Clinic

Career Start Year 2012

Number of shared co-authors 0

Carlos E de Andrea

University of Navarra

Career Start Year 2010

Number of shared co-authors 0

Minhyung Kim

Roswell Park Comprehensive Cancer Center

Career Start Year 2010

Number of shared co-authors 0

Pankaj Vats

Michigan Center for Translational Pathology, University of Michigan ann arbor

Career Start Year 2008

Number of shared co-authors 14

Kris Ylaya

Center for Cancer Research, National Cancer Institute

Career Start Year 2008

Number of shared co-authors 0

Anne Haegert

University of British Columbia

Career Start Year 2008

Number of shared co-authors 9

Esther Herpel

Institute of Pathology, University Hospital Heidelberg

Career Start Year 2005

Number of shared co-authors 1

Albrecht Stenzinger

Institute of Pathology, University Hospital Heidelberg

Career Start Year 2005

Number of shared co-authors 5

Huihui Ye

College of Optical Science and Engineering, Zhejiang University

Career Start Year 2004

Number of shared co-authors 14

Jochen K Lennerz

Massachusetts General Hospital/Harvard Medical School

Career Start Year 2004

Number of shared co-authors 4

Syed Haider

Institute of Cancer Research

Career Start Year 2002

Number of shared co-authors 3

Nicola Fusco

IEO European Institute of Oncology IRCCS

Career Start Year 2002

Number of shared co-authors 2

Frederick Klauschen

Institute of Pathology, Ludwig-Maximilians-Universitat Munchen

Career Start Year 2002

Number of shared co-authors 1

Trevor D McKee

University Health Network

Career Start Year 2001

Number of shared co-authors 0

Beate Rinner

Medical University of Graz

Career Start Year 2000

Number of shared co-authors 0

Pingfu Fu

Case Western Reserve University

Career Start Year 2000

Number of shared co-authors 1

Christopher J Howlett

Western University

Career Start Year 1999

Number of shared co-authors 2

Martijn P Lolkema

Erasmus MC Cancer Institute

Career Start Year 1999

Number of shared co-authors 2

Nam Bui

Stanford University

Career Start Year 1996

Number of shared co-authors 0

Sung Tae Kim

Busan Paik Hospital, Inje University

Career Start Year 1996

Number of shared co-authors 1

Jorge Nieva

Norris Comprehensive Cancer Center, University of Southern California

Career Start Year 1995

Number of shared co-authors 0

Udo Rudloff

Center for Cancer Research, National Cancer Institute

Career Start Year 1994

Number of shared co-authors 0

Craig Gedye

Hunter Medical Research Institute, University of Newcastle

Career Start Year 1993

Number of shared co-authors 2

Sarah M Dry

Jonsson Comprehensive Cancer Center, University of California los angeles

Career Start Year 1992

Number of shared co-authors 1

Jose A Lopez-Martin

Hospital Universitario 12 de Octubre

Career Start Year 1988

Number of shared co-authors 0

Stephen M Hewitt

Center for Cancer Research, National Cancer Institute

Career Start Year 1988

Number of shared co-authors 5

Javed Siddiqui

Michigan Center for Translational Pathology, University of Michigan ann arbor

Career Start Year 1988

Number of shared co-authors 26

Louis Gaboury

Institute for Research in Immunology and Cancer (IRIC), University of Montreal

Career Start Year 1986

Number of shared co-authors 0

Francis J Hornicek

Sylvester Comprehensive Cancer Center, Miller School of Medicine, University of Miami

Career Start Year 1983

Number of shared co-authors 1

David M Berman

Queen's University

Career Start Year 1982

Number of shared co-authors 2

row(s) 1 - 30 of 30

Mark A Rubin

University of Bern

Co-authored papers 18

Himisha Beltran

Dana-Farber Cancer Institute

Co-authored papers 11

Olivier Elemento

Meyer Cancer Center

Co-authored papers 10

Andrea Sboner

Institute for Computational Biomedicine

Co-authored papers 10

Juan Miguel Mosquera

Caryl and Israel Englander Institute for Precision Medicine

Co-authored papers 10

Holger Moch

University Hospital Zurich

Co-authored papers 9

Rohan Bareja

Case Western Reserve University

Co-authored papers 8

Rema Rao

Montefiore Medical Center/Albert Einstein College of Medicine

Co-authored papers 7

Lewis C Cantley

Co-authored papers 7

Brian D Robinson

Sandra and Edward Meyer Cancer Center

Co-authored papers 6

Verena Sailer

Institute for Pathology, University Hospital Schleswig-Holstein

Co-authored papers 6

David M Nanus

Sandra and Edward Meyer Cancer Center

Co-authored papers 5

Myriam Kossai

INSERM, Universite Clermont Auvergne

Co-authored papers 5

Francesca Demichelis

University of Trento

Co-authored papers 5

Scott T Tagawa

Meyer Cancer Center, Weill Cornell Medicine-NewYork Presbyterian Hospital

Co-authored papers 5

Davide Prandi

University of Trento

Co-authored papers 4

Terra J McNary

Co-authored papers 4

Alexandros Sigaras

Columbia University, United States Bureau of Educational and Cultural Affairs Fulbright Program, University of Piraeus, Weill Cornell Medical College, Weill Cornell Medicine

Co-authored papers 4

Loredana Puca

Sandra and Edward Meyer Cancer Center

Co-authored papers 4

Bishoy M Faltas

Sandra and Edward Meyer Cancer Center

Co-authored papers 4

Joanna Cyrta

Paris Sciences Lettres University PSL, Institut CURIE

Co-authored papers 4

Kenneth Eng

Caryl and Israel Englander Institute for Precision Medicine